1.790SEK-12.25%Mkt Cap: 964.22M SEKP/E: —Last update: 2026-06-01
Medivir AB (publ), a pharmaceutical company, focuses on the development and commercialization of medical treatments in areas of high unmet medical need in Sweden, the Nordic region, the rest of Europe, and internationall…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap964.22M SEK
Enterprise Value956.19M SEK
Revenue (TTM)9.01M SEK
Gross Profit-30.81M SEK
Net Income (TTM)-94.40M SEK
Revenue/Share0.0380 SEK
Last Price1.790 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees7
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0020181014
Valuation
P/E (Trailing)—
P/E (Forward)-1.66
PEG0.74
EV/EBITDA-10.76
EV/Revenue106.17
P/S122.02
P/B5.75
EPS (TTM)-0.56
EPS (Forward)-1.23
52W Range
0.340057% of range2.885
52W High2.885 SEK
52W Low0.3400 SEK
Profitability
Gross Margin0.00%
Oper. Margin-872.73%
EBITDA Margin0.00%
Profit Margin-1109.80%
ROE-60.82%
ROA-47.87%
Growth
Revenue Growth83.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-73.35M SEK
CapEx (TTM)—
FCF Margin-661.38%
FCF Yield-6.18%
Net Debt-142.70M SEK
Net Debt/EBITDA1.61
Balance Sheet
Debt/Equity0.05
Current Ratio5.34
Quick Ratio5.34
Book Value/Sh0.3550 SEK
Cash/Share0.2770 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateMay 9, 1996
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)4.979 SEK
Target Range4.000 SEK – 6.937 SEK
# Analysts3
Ownership
Shares Out.538.67M
Float271.03M
Insiders42.33%
Institutions8.59%
Technical
SMA 502.090 (-14.3%)
SMA 2001.252 (+43.0%)
Beta0.11
S&P 52W Chg27.70%
Avg Vol (30d)3.07M
Avg Vol (10d)2.27M
Technical Indicators
RSI (14)53.2
MACD0.0103
MACD Signal-0.0154
MACD Hist.+0.0257
BB Upper2.152 SEK
BB Middle1.915 SEK
BB Lower1.678 SEK
BB Width24.78%
ATR (14)0.1676 SEK
Vol Ratio (20d)0.73x